Branched-Chain Amino Acids Supplementation Does Not Accelerate Recovery after a Change of Direction Sprinting Exercise Protocol.
Chutimon KhemtongAntonio TessitoreSalvador J JaimeGiuliana GobbiJørgen JensenAi-Lun YangChia-Hua KuoGiancarlo CondelloPublished in: Nutrients (2022)
BCAAs supplementation has been widely used for post-exercise recovery. However, no evidence is currently available to answer the question of whether BCAAs supplementation can attenuate muscle damage and ameliorate recovery after a bout of change of direction (COD) sprinting, which is an exercise motion frequently used during team sport actions. This study aimed to assess the effect of BCAAs supplementation on muscle damage markers, subjective muscle soreness, neuromuscular performance, and the vascular health of collegiate basketball players during a 72 h recovery period after a standardized COD protocol. Participants orally received either BCAAs (0.17 g/kg BCAAs + 0.17 g/kg glucose) or placebo (0.34 g/kg glucose) supplementation before and immediately after a COD exercise protocol in a randomized, crossover, double-blind, and placebo-controlled manner. Creatine kinase increased immediately after exercise and peaked at 24 h, muscle soreness remained elevated until 72 h, whilst arterial stiffness decreased after exercise for both supplemented conditions. A negligibly lower level of interleukin-6 was found in the BCAAs supplemented condition. In conclusion, the results of this study do not support the benefits of BCAAs supplementation on mitigating muscle damage and soreness, neuromuscular performance, and arterial stiffness after COD for basketball players.
Keyphrases
- high intensity
- placebo controlled
- double blind
- skeletal muscle
- physical activity
- resistance training
- randomized controlled trial
- oxidative stress
- clinical trial
- healthcare
- public health
- amino acid
- body composition
- type diabetes
- blood glucose
- metabolic syndrome
- risk assessment
- depressive symptoms
- social media
- open label
- palliative care
- locally advanced
- protein kinase
- phase ii study